Kai Havertz’s arrival could be bad news for Chelsea midfielders Ruben Loftus-Cheek and Ross Barkley. Both will have an even harder time in getting minutes on the pitch.

The 21-year-old is a blockbuster signing and you would expect that he will be one of the first names on Frank Lampard’s team sheets week in week out.

It remains unclear in which position Lampard would want to play Havertz in, but considering the Blues have also signed a new right winger this summer, the Germany international would likely play in an attacking midfield role.

Chelsea Unveil New Signing Kai Havertz

(Photo by Darren Walsh/Chelsea FC via Getty Images)

Although the manager tends to play with a midfield-three with two centre-midfielders, Lampard arguably has four other attacking-minded midfielders besides Havertz; Loftus-Cheek, Barkley, Mason Mount and Conor Gallagher.

The latter is expected to head out on another loan spell, with a recent report from the Guardian claimed the young playmaker already had medical with Crystal Palace.

While Mount who made over 50 appearances in all competition in 2019/20 would probably still have a role to play given his versatility and work-rate off the ball.

Chelsea Training Session

(Photo by Darren Walsh/Chelsea FC via Getty Images)

With just three natural wingers; Ziyech, Christian Pulisic, Callum Hudson-Odoi at his disposal, Lampard could slot in Mount as a make-shift winger on the left, while Havertz could also play a back-up winger role on the right.

Loftus-Cheek has also played on the flank under Lampard but given the aforementioned options, the 24-year-old would arguably be behind in the pecking order.

(Photo by Mike Hewitt/Getty Images)

Barkley would likely have it even worse, however.

He played the role of the creative, goal-scoring midfielder under Lampard, and Havertz is arguably an upgraded version of him.

Unless they are content with being squad players, summer exits could be on the cards since they certainly have the quality to become starters elsewhere.

Have something to tell us about this article?